Evaluation of a 24-Gene Signature for Prognosis of Metastatic Events and Prostate Cancer-Specific Mortality

OBJECTIVES: To determine the prognostic potential of Sig24 for identifying prostate cancer patients at risk of developing metastases or experiencing PCSM following radical prostatectomy. SUBJECTS AND METHODS: Sig24 scores were calculated from previously collected gene expression microarray data from...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BJU Int
Main Authors: Pellegrini, Kathryn L., Sanda, Martin G., Patil, Dattatraya, Long, Qi, Santiago-Jiménez, María, Takhar, Mandeep, Erho, Nicholas, Yousefi, Kasra, Davicioni, Elai, Klein, Eric A., Jenkins, Robert B., Karnes, R. Jeffrey, Moreno, Carlos S.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444982/
https://ncbi.nlm.nih.gov/pubmed/28107602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.13779
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares